Results 21 to 30 of about 452,734 (338)

Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma.

open access: yesNew England Journal of Medicine, 2022
BACKGROUND As asthma symptoms worsen, patients typically rely on short-acting β2-agonist (SABA) rescue therapy, but SABAs do not address worsening inflammation, which leaves patients at risk for severe asthma exacerbations.
A. Papi   +11 more
semanticscholar   +1 more source

The Development of Innovative Dosage Forms of the Fixed-Dose Combination of Active Pharmaceutical Ingredients

open access: yesPharmaceutics, 2022
The development of innovative forms of combination drugs is closely related to the invention of the multilayer tablet press, polymers for pharmaceutical applications, the hot-melt extrusion process, and 3D printing in the pharmaceutical industry. However,
Magdalena Janczura   +2 more
semanticscholar   +1 more source

Cost-effectiveness of fixed-dose combination pill (Polypill) in primary and secondary prevention of cardiovascular disease: A systematic literature review

open access: yesPLoS ONE, 2022
Background A significant proportion of cardiovascular disease (CVD) morbidity and mortality could be prevented via the population-based and cost-effective interventions.
R. Jahangiri   +5 more
semanticscholar   +1 more source

Trends in Ezetimibe Prescriptions as Monotherapy or Fixed-Dose Combination in Germany 2012–2021

open access: yesFrontiers in Cardiovascular Medicine, 2022
Aims Addition of ezetimibe to statin therapy is recommended by current guidelines when low-density lipoprotein cholesterol (LDL-C) targets are not achieved with statin monotherapy. Fixed-dose combinations (FDC) improve medication adherence and facilitate
J. Katzmann   +6 more
semanticscholar   +1 more source

High global consumption of potentially inappropriate fixed dose combination antibiotics: Analysis of data from 75 countries

open access: yesPLoS ONE, 2021
Antibiotic fixed dose combinations (FDCs) can have clinical advantages such as improving effectiveness and adherence to therapy. However, high use of potentially inappropriate FDCs has been reported, with implications for antimicrobial resistance (AMR ...
B. Bortone   +5 more
semanticscholar   +1 more source

Fixed-dose combination of rosuvastatin and ezetimibe [PDF]

open access: yesVnitřní lékařství, 2020
Atherosclerotic cardiovascular diseases (ASCVD) play a significant role in morbidity and mortality not only in developed but also increasingly in developing countries. The only causal risk factor (RF) of ASKVO is LDL-cholesterol. The basic pillar of pharmacotherapy of dyslipidaemias are statins, which should be titrated to the maximum (tolerated) dose ...
openaire   +2 more sources

The use of capillary electrophoresis in the simultaneous determination of fixed-dose combination drugs for cardiovascular diseases [PDF]

open access: yesTrends in Pharmaceutical Sciences, 2020
Cardiovascular diseases (CVDs) are the leading cause of mortality worldwide and are usually multifactorial medical conditions. Usually cardiovascular patients must follow a complicated treatment scheme, containing several drugs.
Gabriel Hancu   +3 more
doaj   +1 more source

Optimization of Hypertension Treatment using Fixed-Dose Combination of Perindropril/Amlodipine

open access: yesMajalah Kardiologi Indonesia, 2015
A lot of hypertensive patients require two or more antihypertensive drugs to control and maintain normal blood pressure. Combination of antihypertension is recommended either as first or second line treatment. Among available antihypertension medications,
Evan Hindoro, Arlis Karlina
doaj   +1 more source

Pharmacokinetics of a Fixed-Dose Combination Product of Dapagliflozin and Linagliptin and Its Comparison with Co-Administration of Individual Tablets in Healthy Humans

open access: yesPharmaceutics, 2022
Dapagliflozin, a selective sodium–glucose co-transporter-2 inhibitor, and linagliptin, a competitive, reversible dipeptidyl peptidase-4 inhibitor, are commonly prescribed antidiabetic medications in general clinics.
Jin-Woo Park   +7 more
doaj   +1 more source

Fixed-Dose Combination of NSAIDs and Spasmolytic Agents in the Treatment of Different Types of Pain—A Practical Review

open access: yesJournal of Clinical Medicine, 2021
This review presents the most common disease entities in which combinations of NSAIDs and spasmolytic drugs are used to reduce pain. The benefits of fixed-dose combination products (FDCs) are that they improve the response in people with insufficient ...
Magdalena Janczura   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy